Remote Patient Monitoring Devices Market Is Anticipated To Reach $1.2 Billion By 2022: Grand View Research, Inc.
GrandViewResearch.com has announced the addition of “Global Remote Patient Monitoring Devices Market Analysis And Segment Forecasts To 2022” Market Research report to their Database.
Global remote patient monitoring devices market is expected to reach USD 1.2 billion by 2022, according to a new study by Grand View Research Inc. Remote patient monitoring devices, due to their capability to monitor various chronic conditions such as diabetes, cardiovascular conditions and cancer are expected to experience considerable growth over the forecast period. Increasing prevalence of cardiovascular diseases, rising geriatric population base and the growing demand for independent and healthy living by target patients are some high impact rendering drivers of the remote patient monitoring devices market. Moreover, improving medical infrastructure, increasing post acute care management and demand in the emerging Asia Pacific and Latin American markets are expected to fuel the growth of this market. Rapid technological advancement occurring in the remote patient monitoring devices market is expected to lead towards availability of better option for healthcare practitioners and patients. Remote patient monitoring devices encompass a wide array of technologies designed to manage, evaluate, notify, intervene and modify the treatment plan as required.
Full research report on Global Remote Patient Monitoring Devices Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/remote-patient-monitoring-devices-market
The remote patient monitoring devices are most commonly used to slow the progression of chronic disorders and enhance recovery after getting discharged from an acute care unit. Remote patient monitoring technologies also alert caregivers thereby, enabling prompt intervention.
Image: http://www.abnewswire.com/uploads/fdf4d03cbeede3867a60d193fd4b2e89.png
Global remote patient monitoring devices market, by region, 2012-2022 (USD Million)
Further key findings from the study suggest:
- Heart rate monitors are identified as the most lucrative sub-segment owing to increasing incidences of cardiac related conditions globally.
- Heart rate monitor segment accounted for a significant market share in 2014. The rise in demand for home healthcare and independent living by geriatric population are some factors attributing to the segment’s large market share.
- North America accounted for more than 40% of the remote patient monitoring devices market in 2014 on account of the high demand for technologically advanced products. Presence of sophisticated healthcare infrastructure along with high awareness level of the patients has led to the growth of overall remote patient monitoring devices market.
- Asia Pacific is identified as the most lucrative region of the market due to the presence of large unmet needs in the emerging markets of China and India. Presence of suitable government initiatives to curb the deteriorating environmental conditions and enhancing healthcare infrastructure in Japan and Australia are also expected to attribute to this market’s attractiveness.
- Some key players of remote patient monitoring devices market include Philips, Honeywell, American Telecare, Roche, Philips Healthcare, Bosch, Biotronik, Intel, Welch Allyn, Healthanywhere Inc, Johnson & Johnson and Covidien Plc.
Get more information on Global Remote Patient Monitoring Devices Market or request for sample of this research report at:
http://www.grandviewresearch.com/industry-analysis/remote-patient-monitoring-devices-market
For the purpose of this study, Grand View Research has segmented the global remote patient monitoring devices market on the basis of products, application, end-use and region:
Chapter 1. Executive Summary
1.1. Remote Patient Monitoring Devices– Industry Summary
Chapter 2. Remote Patient Monitoring Devices Industry Outlook
2.1. Remote Patient Monitoring Devices Market Segmentation
2.2. Remote Patient Monitoring Devices Market Size and Growth Prospects
2.3. Remote Patient Monitoring Devices Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis – Porter’s
2.6. Remote Patient Monitoring Devices Company Market Share, 2013
2.7. Remote Patient Monitoring Devices Market PESTEL Analysis, 2013
Chapter 3. Remote Patient Monitoring Devices Market Product Outlook
3.1. Remote Patient Monitoring Devices Market Share By Product, 2013 & 2020
3.2. Vital Sign Monitors
3.2.1. Blood Pressure Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.2.2. Pulse Oximeters Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.2.3. Heart Rate Monitor (ECG) Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.2.4. Temperature Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.2.5. Respiratory Rate Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.2.6. Brain Monitor (EEG) Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3. Special Monitors
3.3.1. Anesthesia Monitors Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3.2. Blood Glucose Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3.3. Cardiac Rhythm Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3.4. Respiratory Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3.5. Fetal Heart Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3.6. Prothrombin Monitor Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3.7. Multi Parameter Monitor (MPM) Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3.8. Others (Ventilators, Infusion Pumps and Others) Market Estimates and Forecasts, 2012 – 2020 (USD Million)
Chapter 4. Remote Patient Monitoring Devices Market Application Outlook
4.1. Remote Patient Monitoring Devices Market Share By Application, 2013 & 2020
4.1.1. Cancer Treatment Market Estimates and Forecasts, 2012 – 2020 (USD Million)
4.1.2. Cardiovascular Diseases Treatment Market Estimates and Forecasts, 2012 – 2020 (USD Million)
4.1.3. Diabetes Treatment Market Estimates and Forecasts, 2012 – 2020 (USD Million)
4.1.4. Sleep Disorder Treatment Market Estimates and Forecasts, 2012 – 2020 (USD Million)
4.1.5. Weight Management and Fitness Monitoring Market Estimates and Forecasts, 2012 – 2020 (USD Million)
Chapter 5. Remote Patient Monitoring Devices Market End-use Outlook
5.1. Remote Patient Monitoring Devices Market Share By End-use, 2013 & 2020
5.1.1. Hospital based patients Market Estimates and Forecasts, 2012 – 2020 (USD Million)
5.1.2. Ambulatory patients Market Estimates and Forecasts, 2012 – 2020 (USD Million)
5.1.3. Home Healthcare Market Estimates and Forecasts, 2012 – 2020 (USD Million)
Chapter 6. Remote Patient Monitoring Devices Regional Outlook
6.1. Remote Patient Monitoring Devices Market Share By Region, 2013 & 2020
6.2. North America
6.2.1. North America Remote Patient Monitoring Devices Market Estimates and Forecasts, by Product, 2012 – 2020 (USD Million)
6.2.1.1. U.S. Market Estimates and Forecasts
6.3. Europe
6.3.1. Europe Remote Patient Monitoring Devices Market Estimates and Forecasts, by Product, 2012 – 2020 (USD Million)
6.3.1.1. Germany Market Estimates and Forecasts
6.3.1.2. UK Market Estimates and Forecasts
6.4. Asia Pacific
6.4.1. Asia Pacific Remote Patient Monitoring Devices Market Estimates and Forecasts, by Product, 2012 – 2020 (USD Million)
6.4.1.1. India Market Estimates and Forecasts
6.4.1.2. China Market Estimates and Forecasts
6.4.1.3. Japan Market Estimates and Forecasts
6.5. Latin America
6.5.1. Latin America Remote Patient Monitoring Devices Market Estimates and Forecasts, by Product, 2012 – 2020 (USD Million)
6.5.1.1. Brazil Market Estimates and Forecasts
6.5.1.2. Mexico Market Estimates and Forecasts
6.6. Middle East and Africa (MEA)
6.6.1. South Africa Market Estimates and Forecasts
Chapter 7. Competitive Landscape
7.1. Abbott Laboratories
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. American Telecare
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Biotronik
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Boston Scientific Corporation
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Covidien Plc
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Draeger Medical
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. GE Healthcare
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Honeywell
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Johnson & Johnson
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. Healthanywhere
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
7.11. Intel
7.11.1. Company Overview
7.11.2. Financial Performance
7.11.3. Product Benchmarking
7.11.4. Strategic Initiatives
7.12. Medtronic
7.12.1. Company Overview
7.12.2. Financial Performance
7.12.3. Product Benchmarking
7.12.4. Strategic Initiatives
7.13. Mindray
7.13.1. Company Overview
7.13.2. Financial Performance
7.13.3. Product Benchmarking
7.13.4. Strategic Initiatives
7.14. Nihon Kohden
7.14.1. Company Overview
7.14.2. Financial Performance
7.14.3. Product Benchmarking
7.14.4. Strategic Initiatives
7.15. Bosch
7.15.1. Company Overview
7.15.2. Financial Performance
7.15.3. Product Benchmarking
7.15.4. Strategic Initiatives
7.16. OSI System
7.16.1. Company Overview
7.16.2. Financial Performance
7.16.3. Product Benchmarking
7.16.4. Strategic Initiatives
7.17. Philips Medical Systems
7.17.1. Company Overview
7.17.2. Financial Performance
7.17.3. Product Benchmarking
7.17.4. Strategic Initiatives
7.18. Roche
7.18.1. Company Overview
7.18.2. Financial Performance
7.18.3. Product Benchmarking
7.18.4. Strategic Initiatives
7.19. Welch Allyn
7.19.1. Company Overview
7.19.2. Financial Performance
7.19.3. Product Benchmarking
7.19.4. Strategic Initiatives
7.20. HealthInterLink
7.20.1. Company Overview
7.20.2. Financial Performance
7.20.3. Product Benchmarking
7.20.4. Strategic Initiatives
7.21. Calsoft labs
7.21.1. Company Overview
7.21.2. Financial Performance
7.21.3. Product Benchmarking
7.21.4. Strategic Initiatives
7.22. Smiths Medical
7.22.1. Company Overview
7.22.2. Financial Performance
7.22.3. Product Benchmarking
7.22.4. Strategic Initiatives
View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information, visit: http://www.grandviewresearch.com/
Blog: http://www.mediafound.org/
Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/05/1432727018.jpeg
“Grand View Research, Inc. – Market Research And Consulting.”
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Email: haakon@grandviewresearch.com
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/remote-patient-monitoring-devices-market
Source: ABNewswire
ReleaseID: 29010
Copyright © 1999-2013 SproutNews.com
